Inventor
WIENHUES-THELEN URSULA-HENRIKE
DE24 patents
⚠️ This page may combine multiple inventors who share the name “WIENHUES-THELEN URSULA-HENRIKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE DIAGNOSTICS OPERATIONS INC
19 patentsUS10557858B2Feb 11, 2020
Biomarkers for risk prediction of mortality
ROCHE DIAGNOSTICS OPERATIONS INC8 citations81
US10488422B2Nov 26, 2019
Use of IGFBP-7 in the assessment of heart failure
ROCHE DIAGNOSTICS OPERATIONS INC7 citations81
US10996229B2May 4, 2021
Use of IGFBP-7 in the assessment of heart failure
ROCHE DIAGNOSTICS OPERATIONS INC2 citations70
US10684291B2Jun 16, 2020
Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
ROCHE DIAGNOSTICS OPERATIONS INC2 citations69
US11454634B2Sep 27, 2022
Assessing whether a subject shall be subjected to imaging based diagnostic
ROCHE DIAGNOSTICS OPERATIONS INC0 citations60
US12517139B2Jan 6, 2026
Biomarkers for risk prediction of mortality
ROCHE DIAGNOSTICS OPERATIONS INC0 citations59
US11874282B2Jan 16, 2024
IGFBP-7 as a marker of preeclampsia
ROCHE DIAGNOSTICS OPERATIONS INC0 citations59
US12117454B2Oct 15, 2024
Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
ROCHE DIAGNOSTICS OPERATIONS INC0 citations58
US11460474B2Oct 4, 2022
Marker for statin treatment stratification in heart failure
ROCHE DIAGNOSTICS OPERATIONS INC0 citations58
US11047866B2Jun 29, 2021
IGFBP7 for diagnosing diastolic dysfunction
ROCHE DIAGNOSTICS OPERATIONS INC0 citations57
US10942175B2Mar 9, 2021
Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
ROCHE DIAGNOSTICS OPERATIONS INC1 citations57
US12480959B2Nov 25, 2025
Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stroke
ROCHE DIAGNOSTICS OPERATIONS INC0 citations56
US10234464B2Mar 19, 2019
Marker for statin treatment stratification in heart failure
ROCHE DIAGNOSTICS OPERATIONS INC0 citations49
US11644472B2May 9, 2023
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation
ROCHE DIAGNOSTICS OPERATIONS INC0 citations46
US10345315B2Jul 9, 2019
IGFBP7 for diagnosing diastolic dysfunction
ROCHE DIAGNOSTICS OPERATIONS INC0 citations46
US11946938B2Apr 2, 2024
Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protein 7 (IGFBP7) for the prediction of stroke
ROCHE DIAGNOSTICS OPERATIONS INC0 citations45
US11397187B2Jul 26, 2022
IGFBP7 for prediction of risk of AKI when measured prior to surgery
ROCHE DIAGNOSTICS OPERATIONS INC0 citations43
US12461113B2Nov 4, 2025
IGFBP7 ratio for HFpEF
ROCHE DIAGNOSTICS OPERATIONS INC0 citations41
US10231639B2Mar 19, 2019
Algorithm of NTproBNP and hand held ECG to detect arrhythmia in an elderly population
ROCHE DIAGNOSTICS OPERATIONS INC0 citations27